Search results
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance via AOL· 9 hours agoAstraZeneca has set a target to become an $80 billion company, in sales, by 2030. In 2023, the...
FDA Expands AstraZeneca's (AZN) Farxiga Label in Pediatric T2D
Zacks via Yahoo Finance· 10 hours agoFollowing the label expansion, AstraZeneca's (AZN) Farxiga is now approved to improve glycemic...
AstraZeneca PLC (OTCMKTS:AZNCF) Sees Large Drop in Short Interest
ETF DAILY NEWS· 16 hours agoAstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) was the recipient of a significant decline in short interest in May. As of May 31st, there was short interest totalling 21,000 ...
Why AstraZeneca plc (NASDAQ:AZN) is Investors’ One of Favorite International Dividend Stock?
Insider Monkey via Yahoo Finance· 2 days agoWe recently compiled a list of 12 Best International Dividend Stocks to Buy Now. Since AstraZeneca...
The No-Brainer Buys: 3 Stocks That Are Absolute Must-Owns Right Now
InvestorPlace via Yahoo Finance· 6 days agoToday, we discuss three must-own stocks as major Wall Street indices reach new highs. The rise in...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 12 hours agoThe company had two earlier flops in COPD treatment, but is now running a Phase 3 study of more than...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 10 hours agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
Meet The International Megacaps That 'Match Or Surpass' Magnificent Seven Stocks
Investor's Business Daily· 3 days agoNovo Nordisk stock also earns a spot on the IBD 50 list of top growth stocks, as well as IBD...
AstraZeneca PLC (NASDAQ:AZN) Receives Consensus Recommendation of “Moderate Buy” from Analysts
ETF DAILY NEWS· 4 days agoAstraZeneca PLC (NASDAQ:AZN – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the nine ratings firms that are currently covering the company, ...
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 3 days agoInvestors should also take note of any recent adjustments to analyst estimates for Astrazeneca....